Showing results (1171-1180 of 1,263) with videos related to

Sort By:
Pageof 127
Journal of the American College of Cardiology|September 2, 2025
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTORFaiez Zannad, Yogesh N V Reddy, Irina Barash, et al.
The Journal of Trauma and Acute Care Surgery|April 30, 2024
The effects of prehospital TXA on mortality and neurologic outcomes in patients with traumatic intracranial hemorrhage: A subgroup analysis from the prehospital TXA for TBI trialSusan Rowell, Eric N Meier, Tatiana Hoyos Gomez, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2002
Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipelineScott A Lesley, Peter Kuhn, Adam Godzik, et al.
BMJ Oncology|June 13, 2025
Mismatch in testing: a retrospective analysis of mismatch repair testing in endometrial cancer and Lynch syndrome diagnosis in multiple specialist centres in the UK and Ireland (March 2022-March 2023)Neil Ryan, Kane Alexander Lennie, Adam Naskretski, et al.
Human Molecular Genetics|March 6, 2016
Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expressionJoel Smith, Martin L Read, Jon Hoffman, et al.
Emerging Infectious Diseases|October 29, 2009
Nosocomial outbreak of novel arenavirus infection, southern AfricaJanusz T Paweska, Nivesh H Sewlall, Thomas G Ksiazek, et al.
European Heart Journal|August 30, 2025
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trialJaved Butler, Francesco Fioretti, Ciaran J McMullan, et al.
Lancet (London, England)|September 2, 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trialJaved Butler, Ciaran J McMullan, Kevin J Anstrom, et al.
The Medical Journal of Australia|February 24, 2022
COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statementEliska Furlong, Rishi S Kotecha, Rachel Conyers, et al.
Nature Ecology & Evolution|April 25, 2018
The ash dieback invasion of Europe was founded by two genetically divergent individualsMark McMullan, Maryam Rafiqi, Gemy Kaithakottil, et al.
Pageof 127